Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06158893Phase 4Unknown
Phase 4, randomised, open-label trial comparing Salbutamol Arm, Budesonide Arm and Placebo Arm (3 arms). Primary endpoint: Incidence of preoperative respiratory adverse events at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06158893.